BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33246213)

  • 1. Generation of three Duchenne Muscular Dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A).
    Souidi M; Amédro P; Meyer P; Desprat R; Lemaître JM; Rivier F; Lacampagne A; Meli AC
    Stem Cell Res; 2020 Dec; 49():102094. PubMed ID: 33246213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51-53 of the dystrophin gene (CCMi003-A).
    Rovina D; Castiglioni E; Farini A; Bellichi M; Gervasini C; Paganini S; Di Segni M; Santoro R; Torrente Y; Pompilio G; Gowran A
    Stem Cell Res; 2019 Oct; 40():101544. PubMed ID: 31465894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of two Duchenne muscular dystrophy patient-specific induced pluripotent stem cell lines DMD02 and DMD03 (MUNIi001-A and MUNIi003-A).
    Jelinkova S; Markova L; Pesl M; Valáškova I; Makaturová E; Jurikova L; Vondracek P; Lacampagne A; Dvorak P; Meli AC; Rotrekl V
    Stem Cell Res; 2019 Oct; 40():101562. PubMed ID: 31526943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Duchenne muscular dystrophy patient-specific induced pluripotent stem cell line lacking exons 45-50 of the dystrophin gene (IITi001-A).
    Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Reiter I; Ramchandren S; Arad M; Michele DE; Binah O
    Stem Cell Res; 2018 May; 29():111-114. PubMed ID: 29653394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C.
    Valetdinova KR; Maretina MA; Vyatkin YV; Perepelkina MP; Egorova AA; Baranov VS; Kiselev AV; Gershovich PM; Zakian SM
    Stem Cell Res; 2020 Oct; 48():101941. PubMed ID: 32777771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of an induced pluripotent stem cell line (FJMUNi001-A) from a patient with Duchenne muscular dystrophy carrying c.4518 + 512 T > A variant in the DMD gene.
    Jin M; Wang D; Li G; Lin J; Lin X; Wang N
    Stem Cell Res; 2022 Apr; 60():102718. PubMed ID: 35247844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of an induced pluripotent stem cell line (ZSYYDNi001-A) from a patient with Duchenne muscular dystrophy carrying exon 51 deletion in the DMD gene.
    Wang L; Li H; Li Y; Xu M; Lin J; Liao Z; Pei Z; Zhang C
    Stem Cell Res; 2021 Oct; 56():102553. PubMed ID: 34619646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C.
    Rovina D; Castiglioni E; Niro F; Farini A; Belicchi M; Di Fede E; Gervasini C; Paganini S; Di Segni M; Torrente Y; Santoro R; Pompilio G; Gowran A
    Stem Cell Res; 2020 May; 45():101819. PubMed ID: 32348941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of two induced pluripotent stem cell lines from Duchenne muscular dystrophy patients.
    Liu W; Zeng W; Kong X; Htet M; Yu R; Wheeler M; Day JW; Wu JC
    Stem Cell Res; 2023 Oct; 72():103207. PubMed ID: 37740996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
    Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Shemer Y; Baskin P; Reiter I; Willi L; Freimark D; Gherghiceanu M; Monserrat L; Scherr M; Hilfiker-Kleiner D; Arad M; Michele DE; Binah O
    J Cell Mol Med; 2019 Mar; 23(3):2125-2135. PubMed ID: 30618214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.
    Eisen B; Binah O
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45-50 into an induced pluripotent stem cell line (CCMi005-A).
    Rovina D; Castiglioni E; Mallia S; Rabino M; Farini A; Belicchi M; Di Giuseppe G; Gervasini C; Torrente Y; Pompilio G; Gowran A
    Stem Cell Res; 2022 Oct; 64():102889. PubMed ID: 35961103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of two induced pluripotent stem cell (iPSC) lines from patients with Duchenne muscular dystrophy (IGIBi006-A and IGIBi008-A) carrying exonic deletions in the dystrophin gene.
    Ahmad I; Goel D; Ghosh A; Kapoor H; Kumar D; Ramesh K; Ashley B; Deepika K; Shastry A; Faruq M
    Stem Cell Res; 2022 Oct; 64():102927. PubMed ID: 36191544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
    Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
    Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro.
    Al Tanoury Z; Zimmerman JF; Rao J; Sieiro D; McNamara HM; Cherrier T; Rodríguez-delaRosa A; Hick-Colin A; Bousson F; Fugier-Schmucker C; Marchiano F; Habermann B; Chal J; Nesmith AP; Gapon S; Wagner E; Gupta VA; Bassel-Duby R; Olson EN; Cohen AE; Parker KK; Pourquié O
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34260377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of five induced pluripotent stem cell lines with DMD/c.497G > T mutation from renal epithelial cells of a Duchenne muscular dystrophy patient and a recessive carrier parent.
    Su J; Wang J; Wang L; Li T; Wang H; Shen J; Wang H; Zhang J; Lin W; Huang J; Liang P
    Stem Cell Res; 2020 Dec; 49():102021. PubMed ID: 33039804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of two genomic-integration-free DMD iPSC lines with mutations affecting all dystrophin isoforms and potentially amenable to exon-skipping.
    Ferrari G; Muntoni F; Tedesco FS
    Stem Cell Res; 2020 Mar; 43():101688. PubMed ID: 32087527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivation of the Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line lacking DMD exons 49 and 50 (CCMi001DMD-A-3, ∆49, ∆50).
    Spaltro G; Vigorelli V; Casalnuovo F; Spinelli P; Castiglioni E; Rovina D; Paganini S; Di Segni M; Nigro P; Gervasini C; Pompilio G; Gowran A
    Stem Cell Res; 2017 Dec; 25():128-131. PubMed ID: 29127875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of ZZUi008-A, a transgene-free, induced pluripotent stem cell line derived from chorionic villi cells of a fetus with Duchenne muscular dystrophy.
    Zhu X; Cai A; Meng J; Liu L; Cui S; Qu S; Zhao J; Liu N; Kong X
    Stem Cell Res; 2018 Oct; 32():47-50. PubMed ID: 30172907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming of human Peripheral Blood Mononuclear Cell (PBMC) from a Chinese patient suffering Duchenne muscular dystrophy to iPSC line (SDQLCHi007-A) carrying deletion of 49-50 exons in the DMD gene.
    Guan J; Liu X; Zhang H; Yang X; Ma Y; Li Y; Gai Z; Liu Y
    Stem Cell Res; 2020 Jan; 42():101666. PubMed ID: 31812072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.